Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Ebastine in Hepatocellular Carcinoma: NCT07734766 Clinical Landscape Report 2026
16 September 2026
NCT07734766 clinical landscape for Hepatocellular Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Docosahexaenoic acid in Multiple Sclerosis: ACTRN12626000924358 Clinical Landscape Report 2026
16 September 2026
ACTRN12626000924358 clinical landscape for Multiple Sclerosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Carboplatin in Ovarian Cancer: NCT07733505 Clinical Landscape Report 2026
16 September 2026
NCT07733505 clinical landscape for Ovarian Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Mepolizumab in Pulmonary Disease, Chronic Obstructive: ISRCTN17701271 Clinical Landscape Report 2026
16 September 2026
ISRCTN17701271 clinical landscape for Pulmonary Disease, Chronic Obstructive: endpoints, sponsor, phase, geography, readouts, asset context and development w…
9 min read
ZP-9830 in Plaque psoriasis: NCT07733089 Clinical Landscape Report 2026
16 September 2026
NCT07733089 clinical landscape for Plaque psoriasis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Isatuximab-IRFC in Multiple Myeloma: NCT07732712 Clinical Landscape Report 2026
16 September 2026
NCT07732712 clinical landscape for Multiple Myeloma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Pembrolizumab in Endometrial Carcinoma: ACTRN12626000937314 Clinical Landscape Report 2026
16 September 2026
ACTRN12626000937314 clinical landscape for Endometrial Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Envafolimab in Hepatocellular Carcinoma: NCT07738055 Clinical Landscape Report 2026
16 September 2026
NCT07738055 clinical landscape for Hepatocellular Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Enzalutamide in Prostatic Cancer: ACTRN12626000947303 Clinical Landscape Report 2026
16 September 2026
ACTRN12626000947303 clinical landscape for Prostatic Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Melatonin in Crohn Disease: NCT07737665 Clinical Landscape Report 2026
16 September 2026
NCT07737665 clinical landscape for Crohn Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Talquetamab in Multiple Myeloma: NCT07740486 Clinical Landscape Report 2026
16 September 2026
NCT07740486 clinical landscape for Multiple Myeloma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
IKS-04 in Pancreatic Ductal Adenocarcinoma: NCT07738939 Clinical Landscape Report 2026
16 September 2026
NCT07738939 clinical landscape for Pancreatic Ductal Adenocarcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white spac…